Source: 4-traders

Cynapsus: Sumitomo Chemical : Cynapsus Therapeutics Receives Shareholder Approval for Sunovion Pharma the Plan of Arrangement

(4-traders.com) Cynapsus Therapeutics Inc. (Cynapsus) (NASDAQ: CYNA) announced that at its special meeting of shareholders and warrantholders (collectively, the Securityholders) held earlier today (the Meeting), Securityholders approved the special resolution (the Arrangement Resolution) authorizing the previously announced plan of arrangement (the Arrangement)...http://www.4-traders.com/SUMITOMO-CHEMICAL-CO-LTD-6491327/news/Sumitomo-Chemical-Cynapsus-Therapeutics-Receives-Shareholder-Approval-for-Sunovion-Pharma-the-Plan-23215584/

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
100-250
Anthony J. Giovinazzo's photo - President & CEO of Cynapsus

President & CEO

Anthony J. Giovinazzo

CEO Approval Rating

68/100

Read more